EMA: Paediatric addendum to CHMP guideline on clinical investigation of medicinal products in the treatment of lipid disorders

This is an addendum to the Guideline on Clinical Investigation of Medicinal Products in the Treatment of Lipid Disorders (EMA/CPMP/3020/2003). It is not meant as a guidance document on its own but rather highlights differences from adult patients with lipid disorders and points out specific paediatric issues.